menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Weighing the Burden of Myelosuppression in SCLC

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
  • Sponsored by

  • Overview

    Current treatment options have led to several challenges, one of them being myelosuppression. How can this impact quality of life for patients with small-cell lung cancer? Dr. Jacob Sands discusses the burden of chemotherapy-induced myelosuppression with Dr. Jared Weiss, Professor of Medicine in the Division of Oncology in the UNC Lineberger Comprehensive Cancer Center.

Recommended
Details
Presenters
  • Sponsored by

  • Overview

    Current treatment options have led to several challenges, one of them being myelosuppression. How can this impact quality of life for patients with small-cell lung cancer? Dr. Jacob Sands discusses the burden of chemotherapy-induced myelosuppression with Dr. Jared Weiss, Professor of Medicine in the Division of Oncology in the UNC Lineberger Comprehensive Cancer Center.

Schedule12 Aug 2022
Webpack App